Abstract: A method of reducing extracellular brain glutamate levels is provided. The method comprising administering to a subject in need thereof an agent capable of modulating stress hormone activity thereby reducing blood glutamate levels, thereby reducing extracellular brain glutamate levels.
Type:
Application
Filed:
March 8, 2007
Publication date:
December 10, 2009
Applicants:
Yeda Research And Development Co. Ltd. at the Weizmann Institute of Sceince, Mor Research Applications Ltd.
Inventors:
Vivian I. Teichberg, Alexander Zlotnik, Yoram Shapira